Cipla Q3 Results FY2026: Pharmaceutical major Cipla Ltd on Thursday reported a sharp 57 per cent YoY decline in its consolidated net profit to Rs 676 crore
for the third quarter of the current financial year (Q3 FY26). The company had posted a net profit of Rs 1,571 crore in the corresponding quarter last year. Its revenue for the quarter under review came in flat at Rs 7,074 crore, compared with Rs 7,073 crore recorded in the same quarter of the previous financial year. Cipla said that its EBITDA fell 37 per cent YoY to Rs 1,254 crore in the reporting three-month period, down from Rs 1,990 crore reported in the December quarter of FY25. The company’s margin witnessed a sharp contraction of over 1,000 basis points, slipping to 17.7 per cent in the quarter.
Cipla Q3 Results: Drop In gRevlimid sales
The Mumbai-based company said that its December 2025 quarter earnings were hit by drop in gRevlimid sales, which dragged the overall North America business.
Umang Vohra, MD and Global CEO, Cipla, in a statement said that the company delivered global revenues of Rs 7,074 crore in the quarter despite the known drop in gRevlimid sales. "Our upcoming launches are expected to cushion gRevlimid revenue decline and provide long-term growth," he said.
Going ahead, Vohra said, "the focus will be on growing our key markets, further building our flagship brands, investing in future pipeline as well as focusing on resolutions on the regulatory front.”
Cipla Q3 Results: Key Highlights
One-India: Delivered a strong growth of 10 per cent YoY for the quarter. Overall Chronic mix improved to 62.3 per cent in the market.
North America: Delivered quarterly revenue of USD 167 million.
One Africa: Prescription business ranked No. 2 in the market.
Emerging Markets and Europe: Delivered fourth consecutive quarterly revenue above USD 100Mn+, recording a 7 per cent YoY growth in USD terms.
R&D investments: Stood at Rs 494 crore, accounting for 7 per cent of sales, up 37.4 per cent YoY, driven by increased product filings and development initiatives.
Strong net cash: Net cash position of Rs 10,229 crore; debt primarily includes lease liabilities.
Meanwhile, Cipla shares cracked nearly 5 per cent to make an intraday low of Rs 1,303 on NSE post announcement of the quarterly results. Around 2 PM, Cipla shares traded 3.2 per cent lower at Rs 1,327.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
